68.18
price down icon1.52%   -1.05
after-market Dopo l'orario di chiusura: 68.20 0.02 +0.03%
loading
Precedente Chiudi:
$69.23
Aprire:
$68.92
Volume 24 ore:
4.43M
Relative Volume:
0.89
Capitalizzazione di mercato:
$26.74B
Reddito:
$4.30B
Utile/perdita netta:
$571.50M
Rapporto P/E:
47.73
EPS:
1.4285
Flusso di cassa netto:
$570.80M
1 W Prestazione:
-3.56%
1M Prestazione:
+2.59%
6M Prestazione:
-4.38%
1 anno Prestazione:
-5.62%
Intervallo 1D:
Value
$67.80
$69.10
Intervallo di 1 settimana:
Value
$66.42
$72.08
Portata 52W:
Value
$57.52
$93.25

Dexcom Inc Stock (DXCM) Company Profile

Name
Nome
Dexcom Inc
Name
Telefono
(858) 200-0200
Name
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Dipendente
10,300
Name
Cinguettio
@dexcom
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
DXCM's Discussions on Twitter

Confronta DXCM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
DXCM
Dexcom Inc
68.18 27.15B 4.30B 571.50M 570.80M 1.4285
Medical Devices icon
ABT
Abbott Laboratories
124.43 220.36B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
100.30 149.61B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
369.59 143.72B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
91.73 119.58B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
82.69 48.25B 5.69B 1.41B 577.90M 6.9828

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-21 Ripresa Stifel Buy
2025-09-08 Downgrade Oppenheimer Outperform → Perform
2025-08-21 Iniziato Argus Buy
2025-06-16 Iniziato Truist Buy
2025-05-30 Iniziato Goldman Buy
2025-04-10 Iniziato Mizuho Outperform
2025-02-03 Aggiornamento Redburn Atlantic Neutral → Buy
2025-01-16 Aggiornamento Robert W. Baird Neutral → Outperform
2024-07-26 Downgrade JP Morgan Overweight → Neutral
2024-07-26 Downgrade Robert W. Baird Outperform → Neutral
2024-05-30 Iniziato Redburn Atlantic Neutral
2024-03-12 Iniziato RBC Capital Mkts Outperform
2023-05-30 Ripresa Morgan Stanley Equal-Weight
2023-04-17 Aggiornamento Raymond James Outperform → Strong Buy
2023-03-29 Iniziato UBS Buy
2023-01-26 Iniziato Wolfe Research Outperform
2022-10-18 Iniziato Barclays Equal Weight
2022-10-12 Iniziato Jefferies Buy
2022-07-15 Iniziato Bernstein Outperform
2022-03-02 Ripresa BofA Securities Buy
2022-02-03 Aggiornamento BTIG Research Neutral → Buy
2022-01-19 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-01-07 Aggiornamento Guggenheim Neutral → Buy
2021-10-18 Downgrade Guggenheim Buy → Neutral
2021-07-21 Ripresa Cowen Outperform
2021-05-28 Aggiornamento Wells Fargo Underweight → Equal Weight
2021-05-25 Iniziato Barclays Overweight
2021-04-15 Iniziato Atlantic Equities Overweight
2021-01-06 Aggiornamento UBS Neutral → Buy
2020-10-02 Downgrade Wells Fargo Equal Weight → Underweight
2020-05-27 Reiterato Piper Sandler Overweight
2020-05-14 Iniziato Wells Fargo Equal Weight
2020-03-05 Iniziato Citigroup Buy
2019-11-07 Reiterato Canaccord Genuity Buy
2019-11-07 Aggiornamento Guggenheim Neutral → Buy
2019-10-23 Iniziato Stifel Buy
2018-11-28 Iniziato UBS Neutral
2018-10-19 Aggiornamento Goldman Sell → Neutral
2018-09-12 Aggiornamento Northland Capital Under Perform → Market Perform
2018-08-02 Reiterato Canaccord Genuity Buy
2018-07-02 Aggiornamento Raymond James Mkt Perform → Outperform
2018-06-08 Aggiornamento JP Morgan Neutral → Overweight
2018-05-11 Iniziato BofA/Merrill Buy
2018-05-03 Reiterato Canaccord Genuity Buy
2018-04-04 Iniziato Goldman Sell
2018-04-04 Iniziato Guggenheim Neutral
2018-03-23 Aggiornamento Robert W. Baird Neutral → Outperform
2018-01-04 Downgrade Northland Capital Market Perform → Under Perform
2017-09-28 Reiterato Wedbush Outperform
Mostra tutto

Dexcom Inc Borsa (DXCM) Ultime notizie

pulisher
12:00 PM

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

12:00 PM
pulisher
10:29 AM

DEXCOM ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire

10:29 AM
pulisher
08:08 AM

DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

08:08 AM
pulisher
06:46 AM

Will breakout in DexCom Inc. lead to full recovery2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com

06:46 AM
pulisher
05:47 AM

What does recent volatility data suggest for DexCom Inc.2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com

05:47 AM
pulisher
03:49 AM

Can technical indicators confirm DexCom Inc.’s reversal2025 Short Interest & Daily Profit Focused Screening - newser.com

03:49 AM
pulisher
03:24 AM

DexCom Inc. stock daily chart insightsEarnings Risk Report & Weekly Watchlist for Consistent Profits - newser.com

03:24 AM
pulisher
Oct 28, 2025

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - Morningstar

Oct 28, 2025
pulisher
Oct 28, 2025

DexCom (DXCM) Expands Board with Appointment of Dr. Euan Ashley - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors - The AI Journal

Oct 28, 2025
pulisher
Oct 28, 2025

Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The AI Journal

Oct 28, 2025
pulisher
Oct 28, 2025

Portnoy Law Firm Announces Class Action on Behalf of DexCom, Inc. Investors - GlobeNewswire

Oct 28, 2025
pulisher
Oct 28, 2025

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor - Benzinga

Oct 28, 2025
pulisher
Oct 28, 2025

DexCom (DXCM) Shares Dip as Hunterbrook Issues Short Report - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed DexCom, Inc. (DXCM) - GlobeNewswire Inc.

Oct 28, 2025
pulisher
Oct 28, 2025

Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices - Stocktwits

Oct 28, 2025
pulisher
Oct 28, 2025

DexCom falls as Hunterbrook releases new short report (DXCM:NASDAQ) - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

AstraZeneca non-executive director Euan Ashley joins DexCom board By Investing.com - Investing.com Nigeria

Oct 28, 2025
pulisher
Oct 28, 2025

DexCom Shares Fall After Hunterbrook Report on Incidents Related to G7 Glucose Monitor - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Dexcom (DXCM) Faces Scrutiny Following Reports of Glucose Monito - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

DexCom (DXCM) Shares Fall 2% Following Short Report - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Oct 28, 2025
pulisher
Oct 28, 2025

Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption? - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

AstraZeneca non-executive director Euan Ashley joins DexCom board - Investing.com

Oct 28, 2025
pulisher
Oct 28, 2025

DexCom: Powering The Future Of Glucose Monitoring And Digital Care - RTTNews

Oct 28, 2025
pulisher
Oct 28, 2025

Is DexCom Inc. (DC4) stock a buy for dividend portfoliosTrade Analysis Summary & Verified Entry Point Detection - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What MACD trends signal for DexCom Inc. (DC4) stockJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What catalysts could drive DexCom Inc. stock higherTrade Exit Report & Consistent Profit Trading Strategies - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How DexCom Inc. stock performs in interest rate cyclesQuarterly Growth Report & Technical Entry and Exit Tips - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Is DexCom Inc. stock reversal real or fakeMarket Growth Report & Risk Managed Investment Entry Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Can DexCom Inc. stock sustain free cash flow growthMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

DexCom Inc. stock chart pattern explainedWeekly Profit Analysis & AI Based Trade Execution Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will DexCom Inc. stock maintain momentum in 2025Quarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom appoints Stanford’s Euan Ashley to board of directors - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom appoints Stanford’s Euan Ashley to board of directors By Investing.com - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom appoints Euan Ashley to board of directors - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom Appoints Euan Ashley To Board Of Directors - TradingView

Oct 27, 2025
pulisher
Oct 27, 2025

Dexcom Appoints Euan Ashley to Board of Directors - The Joplin Globe

Oct 27, 2025
pulisher
Oct 27, 2025

DexCom, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo

Oct 27, 2025
pulisher
Oct 27, 2025

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal

Oct 27, 2025
pulisher
Oct 27, 2025

Is DexCom Inc. stock attractive for passive investorsDay Trade & Weekly Top Stock Performers List - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What MACD and RSI say about DexCom Inc.Portfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will a bounce in DexCom Inc. offer an exit2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com

Oct 27, 2025

Dexcom Inc Azioni (DXCM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices PHG
$27.60
price up icon 1.10%
medical_devices STE
$236.79
price down icon 1.83%
$316.17
price down icon 2.52%
$77.38
price down icon 2.54%
medical_devices EW
$82.69
price up icon 0.61%
Capitalizzazione:     |  Volume (24 ore):